PubRank

Clinical lipidology (Clin Lipidol)

Journal PubWeight™ 48.24‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Mechanisms and clinical implications of hepatocyte lipoapoptosis. 2010 1.07
2 Perivascular adipose tissue and vascular disease. 2011 0.98
3 Regulation of microsomal triglyceride transfer protein. 2011 0.97
4 The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking. 2012 0.96
5 Apolipoproteins in the brain: implications for neurological and psychiatric disorders. 2010 0.93
6 Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia. 2010 0.93
7 Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices. 2009 0.92
8 HDL as a contrast agent for medical imaging. 2009 0.92
9 Lysophosphatidic acid effects on atherosclerosis and thrombosis. 2011 0.91
10 Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease. 2012 0.91
11 Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo. 2009 0.89
12 Mammalian diseases of phosphatidylinositol transfer proteins and their homologs. 2010 0.89
13 Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. 2011 0.89
14 Mechanisms of lipase maturation. 2010 0.88
15 Thromboxane and the thromboxane receptor in cardiovascular disease. 2010 0.86
16 Lysosomes, cholesterol and atherosclerosis. 2010 0.86
17 Examining the role of lipid mediators in diabetic retinopathy. 2012 0.86
18 A new model system swims into focus: using the zebrafish to visualize intestinal metabolism in vivo. 2009 0.85
19 Guardian of corpulence: a hypothesis on p53 signaling in the fat cell. 2009 0.84
20 Role of preadipocyte factor 1 in adipocyte differentiation. 2010 0.84
21 Management of dyslipidemia in HIV-infected patients. 2011 0.83
22 Niemann-Pick type C pathogenesis and treatment: from statins to sugars. 2010 0.83
23 Lipid signals and insulin resistance. 2013 0.82
24 Caveolae and lipid trafficking in adipocytes. 2011 0.81
25 Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease? 2012 0.81
26 Associations of BMI and its fat-free and fat components with blood lipids in children: Project HeartBeat! 2011 0.81
27 Mechanisms of oxysterol-induced disease: insights from the biliary system. 2012 0.81
28 Lipoprotein(a) and cardiovascular disease in diabetic patients. 2012 0.81
29 The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol. 2015 0.80
30 Clinical applications of advanced lipoprotein testing in diabetes mellitus. 2011 0.80
31 Lipoproteins and lipoprotein metabolism in periodontal disease. 2010 0.79
32 Regulating intestinal function to reduce atherogenic lipoproteins. 2013 0.79
33 Sleep, sleep-disordered breathing and lipid homeostasis: translational evidence from murine models and children. 2012 0.79
34 Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress. 2009 0.79
35 Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis. 2013 0.78
36 Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy. 2012 0.77
37 The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis. 2011 0.77
38 Formation of milk lipids: a molecular perspective. 2015 0.77
39 Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation. 2011 0.77
40 Variations in lipid levels according to menstrual cycle phase: clinical implications. 2011 0.77
41 Novel method for reducing plasma cholesterol: a ligand replacement therapy. 2015 0.77
42 Setting the course for apoAII: a port in sight? 2013 0.77
43 Testosterone, HDL and cardiovascular risk in men: the jury is still out. 2012 0.77
44 Role of long-chain and very-long-chain polyunsaturated fatty acids in macular degenerations and dystrophies. 2011 0.77
45 Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors. 2015 0.77
46 The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis. 2015 0.76
47 The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus. 2015 0.76
48 CPT1A: the future of heart disease detection and personalized medicine? 2015 0.76
49 Hepatobiliary transport in health and disease. 2012 0.76
50 Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia. 2015 0.75
Next 50